Evolv Technologies Holdings heads into the final week of June with a quiet but steady short rebuild underway, the stock still 10% below its month-ago level despite a modest recovery, and analysts holding targets that imply nearly 75% upside from current prices.
The short-side story is modest but directionally clear. Short interest has climbed roughly 20% over the past month to 4.6% of the free float — about 8.1 million shares — after a sharp step-up from the roughly 6.8 million share base seen in late May. That move is the most interesting development in the positioning data right now. On its own, 4.6% of float is not an extreme reading, but the pace of increase flags fresh conviction from bears rather than stale carry. The borrow market itself remains wide open: availability is at 3,557%, meaning there are roughly 35 shares available for every share currently borrowed, comfortably above even the 52-week low of 750%. Cost to borrow is essentially negligible at 0.44%, even with a 42% week-on-week jump that in absolute terms takes it nowhere near restrictive. There is no squeeze pressure here. Options positioning tells a similar, unthreatened story — the put/call ratio is running at 0.22, modestly above its 20-day average of 0.20 and less than one standard deviation from the mean. The market is leaning call-heavy; options traders are not hedging.
The Street lines up squarely on the bullish side, yet the stock has not followed. All four analysts with active ratings carry Buy or Outperform designations, and the consensus price target of $10.13 is 75% above the current $5.80. The most recent action, TD Cowen reiterating its Buy at $10 on June 9, is the clearest signal that coverage is not wavering. The bull case rests on 29% year-over-year revenue growth to $32.5 million, 100 new system orders in Q2 2025, and a subscription model shift that carries better unit economics. Bears counter with the path to free cash flow — the EV/EBITDA multiple of 53x on a company still burning cash asks investors to carry significant patience. The EPS momentum factor scores sit at just 8 out of 100, and the negative P/E of -118x underlines the losses still on the income statement. Factor scores are a mixed bag: EPS surprise ranks at 83, and forward EPS improvement (71st percentile) speaks to analyst optimism, but dividend score (22), short-score rank (41), and DTC rank (32) all signal a name that the broader quant community treats with caution.
Insider activity from the past month is worth a note, though it is not alarming. Founder and director Michael Ellenbogen sold 80,745 shares at $6.21 on June 15 for roughly $500,000 — a meaningful name with meaningful shares, and the sale came on the way down from the $7 range. Robert Marshall, a chief-level officer, sold 62,000 shares on June 2 at $6.85. Both transactions look like planned or opportunistic trimming rather than a structural exit: the 90-day net insider position across all insiders is actually positive at roughly 356,000 shares, largely because of equity awards to the board in mid-June. The awards themselves carry zero cash value but signal continued director engagement.
Earnings are on the calendar for August 11. The last four prints have produced day-one moves of -1.4%, +0.3%, -5.3%, and -13.0% — three of four in the red, with the five-day drift following the bad prints running worse than the initial reaction. The stock is currently trading below where it stood after each of those releases. What to watch between now and August is whether the short rebuild continues past the 5% of float threshold, and whether the cost-to-borrow — still historically low — begins to move in tandem as availability tightens.
See the live data behind this article on ORTEX.
Open EVLV on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
